Delivery Order SPE2DE21D7020-SPE2D625F3AWU
- Not listed
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp on August 15, 2025, for agent drug-coated balloons, with a ceiling value of $13,590.30. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The award carries no set-aside designation, indicating open competition in the federal marketplace. Drug-coated...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- The Defense Health Agency's Medical Supply Chain awarded Boston Scientific Corp a fixed-price delivery order valued at $7,524.80 for drug-coated balloon medical devices, with an ultimate completion date of August 29, 2025. The contract, which is not set-aside and uses economic price adjustment pricing, will be performed at Boston Scientific's Marlborough, Massachusetts facility. This delivery order represents a discrete procurement under the agency's broader medical device supply chain...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons with a ceiling value of $6,175. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 21, 2025. This delivery order was not set aside for any specific business category and will be performed at Boston Scientific's Marlborough, Massachusetts facility. As a prime contractor, Boston Scientific is...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons, with a contract ceiling value of $6,175. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts. This delivery order represents no set-aside...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3AWUDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for drug-coated balloons on September 10, 2025, with a contract ceiling value of $6,175 and an ultimate completion date of September 17, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures its medical device portfolio. Boston Scientific, a global medical technology company specializing in cardiovascular and interventional medical equipment, serves as a critical supplier to federal healthcare agencies. The company maintains an extensive history of federal contract awards through the Defense Health Agency and Veterans Affairs, providing specialized medical devices including pacemakers, stents, catheters, and various cardiovascular intervention tools. This delivery order for drug-coated balloons aligns with Boston Scientific's established role as a primary federal contractor for advanced cardiac intervention devices, further supporting the Defense Health Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/10/25 |